August 2021

New Compounding Formulations

Compounding Formulas

The following formulations have been added to the master formula registry:

  • Lapatinib 50 mg/mL oral suspension (Ora-Blend) (tablets)
  • Erlotinib 10 mg/mL oral suspension (Ora-Blend) (tablets)
  • Imatinib 40 mg/mL oral suspension (Ora-Sweet) (tablets)
  • Nadolol 10 mg/mL oral suspension (Oral Mix) (tablets)

You can access the formulations by using the Search box or through the module entitled Compounding Formulas.

July 2021


Patient Handouts
A new patient handout concerning scleroderma is now available. It describes the most common symptoms and when to consult a health care professional, among others. You can access the handout via our Patient Information Sheets index or by using the search field on the homepage.
May 2021

Reworked dressing-related information

With a view of always providing you with reliable and updated information, our team introduces a new tool called Dressings, which now uses class-specific information sheets to display the information. This tool centralizes dressings-related information. It replaces the monographs, the comparative chart and the dynamic comparison tool that were previously available.
April 2021

Respiclick instructions

Patient Information Sheets
We've developed a new patient document with illustrated instructions for using the Respiclick inhaler. Patients who are concerned about properly taking their medication will no doubt find it useful. You can access the document through our Information Sheets index or by running a search on your home screen.
March 2021

Magic mouthwash section: Revised and expanded

Compounding Formulas
We have revised and improved the section on magic mouthwash formulas. If you know the name of the formula you're looking for, simply type it in the search field. If you only know the ingredients, check the corresponding boxes in the magic mouthwash index. Any formulas not containing those ingredients will be filtered out.
February 2021

Compounding Formulas Registry

Compounding Formulas
The master formulations contained in the Compounding Formulas module are subject to periodic revisions. Our team takes note of new data published in the literature, thus ensuring that the formulas contained in our registry remain well referenced and supported by reliable stability data. As a result, a formula may be removed from the register when recent data no longer justifies its preparation.
January 2021

Parenteral Drug Administration

Professional Documentation
The comparative chart on hypoglycemic agents and the monographs for certain agents, including canagliflozin, dapagliflozin, empagliflozin, have been modified following the updated Diabetes Canada guidelines for the management of type 2 diabetes in adults. You can access these documents via the Search field on the homepage.
December 2020

Meningococcal disease and tooth decay

Patient Information Sheets
We have created new information sheets about meningococcal disease and about tooth decay. You can access this information via the index at the bottom of the homepage or by using the search field.
November 2020

Addition of the Pediatric Pharmacy Association's KIDs List 2020

The KIDs List is a list of potentially inappropriate drugs for pediatric use. It was developed by pharmacists who are members of the Pediatric Pharmacy Association. Its objectives include promoting the safe use of medications in pediatrics by serving as a guide for clinical decision-making.

We have added the KIDs List information in the Pediatric Dosage section of the relevant medications monograph.
October 2020

Directions for use for Byetta® and Victoza®

Patient Information Sheets
We've developed two new patient documents with illustrated instructions for using the injectable medications Byetta® and Victoza®. Patients who are concerned about properly administering their injections will no doubt find them useful.

You can access the handout via our Patient Information Sheets index or by using the search field on the homepage.
September 2020

NAPRA standard for the compounding formulas

Professional documentation
Pharmacists outside of Quebec will be glad to learn that the categories for master formulations, previously based on USP 795 standards, are now based on the National Association of Pharmacy Regulatory Authorities (NAPRA) standard. Note that the OPQ standard remains in effect in Quebec. The August version of RxVigilance also includes two new documents relating to the standard for pharmacy compounding of non-sterile preparations, namely the model standards and the guidance document.
August 2020

Drugs used to treat asthma

Comparative Drug Charts
We have updated our chart on Drugs used to treat asthma. In addition to revising the content, we have added several useful links about the various inhaler devices. This chart can be accessed from the index at the bottom of the home screen or directly from the search field.
July 2020

Redesign of the Adverse effects section

We have made changes to the Adverse effects section of our monographs. One of the changes you will notice is that this section is now divided into subsections. These subsections include a detailed list of adverse effects, a presentation of adverse effects by system, possible effects on laboratory tests, and a summary of the most common or relevant adverse effects, when available.
June 2020

Drugs used to treat COPD

Comparative Drug Charts
We have updated our chart on Drugs used to treat COPD. In addition to having reviewed the content, we have also added several useful links to the various inhalation devices. You can access the chart via the index at the bottom of the homepage or by using the search field.
May 2020

Useful informations

To provide quick and easy access to reliable resources, our team has created a web page containing useful links about COVID-19 all in one place. You can access it by clicking the icon at the top of the homepage or directly via the Search field.
March 2020

Travel information for professionals

Professional Reference

To properly advise your patients on travel immunization and malaria chemoprophylaxis, you can obtain information by consulting the references in the Professional Reference under the Immunization and Travel heading. You can access the Professional Reference from the bottom of the homepage, or by using the Search box.

February 2020

Intrauterine Contraception

Comparative Drug Charts

We recently created a brand new explanatory document on Intrauterine Contraception. You will find comparative data on the various copper and levonorgestrel IUDs, as well as information on their benefits and side effects, among others. To access, go to the Comparative Drug Charts index at the bottom of the homepage, or use the Search box.

January 2020

Travel Health Information by Destination

Information Sheets

We recently completed a visual overhaul of the Travel-Health Information leaflets to optimize viewing, making them, among other things, fully optimized for mobiles devices. These handouts contain a wide range of useful information (e.g., vaccines, medications, sanitation issues and emergency contact numbers). To access, go to the Travel-Health index at the bottom of the homepage, or use the Search box.

December 2019

Antiretrovirals for the treatment of HIV infection

Comparative Drug Chart

We have a comparative chart for drugs used in the treatment of HIV infection. Among other things, you will find antiretroviral drug regiments and information about pre-exposure and postexposure prophylaxis.

October 2019

Acetaminophen and Ibuprofen Dosage for Children

Information Sheets

We have updated our patient handouts on acetaminophen and ibuprofen dosages for children. The visual aid in particular has been optimized, and is now more user-friendly. You can access the handout via the Patient Information Sheets index at the bottom of the homepage or by using the Search box.

August 2019

INESSS Documents

Professional Documentation

Two of INESSS's national medical protocols (the protocol on warfarin adjustment and the protocol on antihypertensive medication adjustment) have been added to the professional documentation. You can access these documents via the Professional Documentation link at the bottom of the screen or by using the Search box. [French only]

June 2019

ONTarget - Resource Guide


The links in certain product monographs that took readers to OnTarget documents have been replaced with links that now take readers directly to the OnTarget site. At the moment, this website requires users to create an account. We are currently working with OnTarget to allow direct access to this resource.

June 2019

Plaque psoriasis

Comparative Drug Chart

We have developed a comparative chart that deals with the drugs used to treat plaque psoriasis. It includes information on the pathophysiology of psoriasis, as well as treatment principles such as biologic agents.

May 2019

Biosimilar Biologic Drugs

Professional Documentation

Two documents on biosimilar biologics, published by the Canadian Agency for Drugs and Technologies in Health (CADTH), have been added to the Professional Documentation section. The first one is intended for health professionals, while the second one is for patients.

April 2019

List of Hazardous Drugs


NIOSH has removed risperidone and paliperidone from its list of hazardous drugs. Changes have been made to the product monographs in question.

March 2019

Drugs used to treat hypertension

Comparative Drug Chart

We have added a comparative chart for drugs used to treat hypertension. This document also includes a summary of Hypertension Canada's latest guidelines.

February 2019

Perioperative management of oral anticoagulants

Comparative Drug Chart

A section on perioperative management has been added to the oral anticoagulants comparative drug chart. This section provides relevant information on what to consider when faced with making a clinical decision to interrupt or continue anticoagulation before surgery or a procedure, based on the risk of surgical bleeding and on the patient's thromboembolic risk.

January 2019

Documents from the Institut universitaire de gériatrie de Montréal

Professional Documentation

Documents entitled You May Be at Risk, published by the Institut universitaire de gériatrie de Montréal, have been added to our Professional Documentation. They explain to patients the risks associated with certain classes of drugs. These include antipsychotics, proton pump inhibitors, sedative-hypnotics, sulfonylureas, non-steroidal anti-inflammatories and antihistamines.

December 2018

Chronic Kidney Disease

Professional documentation

A document on chronic kidney disease has been added to the Professional Documentation. To refer to it, use the search field or click on the link in the Renal Impairment section of our monographs.

November 2018

Profile Analysis

Dynamic Tools

You may now begin to familiarize yourselves with our brand new analysis engine. To access, simply click on the link entitled Profile Editor (New!) located in the dynamic tools column at the bottom centre of the main RxVigilance menu. Our software developers will be integrating the new engine over the course of the next few months. We are always available to answer any questions or comments you may have.

Septembre 2018

Phone Book

New platform

Vigilance Santé, in partnership with Clinia, is proud to announce that the phone book will be migrating to a new platform! In addition to having access to the same useful information, you will be able to enjoy new functions (business hours, services offered, interactive map, ability to update pharmacy-related information, etc.). The new platform, developed in collaboration with Clinia, can also be used to gather information on other useful health resources (medical clinics, collection centres, etc.). If you had manually entered personal numbers into your directory, do not hesitate to contact our customer service department for help on retrieving them.